Guided by our passion for innovative science, Guardian Research partners with leading pharmaceutical, biotechnology, and medical device companies worldwide.
Guided by our passion for innovative science, Guardian Research is committed to working with some of the most reputable pharmaceutical, biotechnology, and medical device companies in the world in testing treatment interventions in therapeutic areas where we believe we have an opportunity to make a meaningful difference for patients. Currently, Guardian Research responds to multiple clinical trial opportunities in the following therapeutic areas:
Clinical trials on diseases and conditions that affect the structure and function of the heart and blood vessels, including but limited to:
Clinical trials on diseases and conditions that affect that affect hormone-producing glands such as the pituitary, thyroid, ovary and testis, including but limited to:
Clinical trials on diseases and conditions that affect that affect the gastrointestinal organs, including but limited to:
Clinical trials on medical conditions caused by the invasion of a pathogen, including bacteria, viruses, fungi and parasites, including:
Clinical trials on diseases and conditions that affect the kidneys and urinary tract, including but limited to:
Clinical trials on diseases and conditions that affect the neurological system, including but limited to:
Clinical trials on diseases and conditions that affect the respiratory system, including but limited to:
Clinical trials on diseases and conditions that affect the joints, muscles, and bones, including but limited to: